[Raised tattoos in a human-immunodeficiency-virus-infected patient].
García-Lázaro
Milagros
M
Unidad de Enfermedades Infecciosas, Hospital Reina Sofía, Córdoba, España. milagrosglazaro@telefonica.net
Villar
Carlos
C
Natera
Clara
C
Rivero
Antonio
A
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D000328:Adult; D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D019698:Hepatitis C, Chronic / Q000150:complications; D006644:Histiocytes / Q000473:pathology; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use; D016773:Leishmaniasis, Cutaneous / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D007898:Leishmaniasis, Visceral / Q000150:complications; D061466:Lopinavir; D008297:Male; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use; D010349:Patient Compliance; D010419:Pentamidine / Q000008:administration & dosage / Q000627:therapeutic use; D011744:Pyrimidinones / Q000008:administration & dosage / Q000627:therapeutic use; D012008:Recurrence; D019438:Ritonavir / Q000008:administration & dosage / Q000627:therapeutic use; D013653:Tattooing; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use
D019380:Anti-HIV Agents; D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D011744:Pyrimidinones; D061466:Lopinavir; D019259:Lamivudine; D015215:Zidovudine; D010419:Pentamidine; D008536:Meglumine; D000077485:Meglumine Antimoniate; D019438:Ritonavir